Floatz logo

DEXKETOPROFEN

Knee Disease

Poznan University of Medical SciencesSmall moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

7 Active assets in the Knee Disease cohort.

Asset / SponsorPhaseRating
Bxcl501
Poznan University of Medical Sciences
Phase 4BB
DEXAMETHASONE
Poznan University of Medical Sciences
Phase 4BB
ROPIVACAINE
Poznan University of Medical Sciences
Phase 4BB
NEPENTHE
Poznan University of Medical Sciences
Phase 4BB
METAMIZOLE
Poznan University of Medical Sciences
Phase 4BB

View all 9 →

Same molecule, other indications

DEXKETOPROFEN is also rated in:

migraine disorderDormant
BBB
Indicative ·
73 / 100
View asset →
migraine without auraDormant
BB
Indicative ·
68 / 100
View asset →
Carcinoma, HepatocellularDormant
BB
Indicative ·
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →